Breaking News
Atossa Therapeutics 2025 Financial Results Analysis
Atossa Therapeutics, Inc. (ATOS) posted Q4 2025 GAAP EPS of -$4.04.
1 articles, transcripts, and reports
Atossa Therapeutics, Inc. (ATOS) posted Q4 2025 GAAP EPS of -$4.04.